“She is a rising star who excels on the merger control, FTC side.”
“She is really spectacular. She really gets to the heart of the issues.”
The Who’s Who Legal - Future Leaders 2017 in Competition 

“She gets deep into the core drivers of our business to provide best in class counsel and impresses for her work in both antitrust litigation and mergers.” 
Chambers USA 2017-2020

Amanda P. Reeves

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA

Mandy Reeves is a globally recognized partner in the Litigation & Trial Department of Latham & Watkins and serves as Global Chair of the firm’s Antitrust & Competition Practice. She particularly focuses on the application of the antitrust laws to the healthcare, life sciences, and high technology industries.

Ms. Reeves’ antitrust practice runs the gamut from representing clients in Federal Trade Commission (FTC) and the United States Department of Justice (DOJ) investigations into mergers and alleged anticompetitive conduct to defending clients in antitrust litigations, raising novel issues. She has experience at all phases of government antitrust investigations and is an experienced litigator.

Ms. Reeves rejoined Latham in 2011 after spending two years serving as Attorney Advisor to Commissioner J. Thomas Rosch at the FTC. In that capacity she was responsible for advising Commissioner Rosch on all aspects of competition law, including merger and anticompetitive practice investigations, litigation and appellate strategy, the IP/antitrust interface, and policy matters.

Ms. Reeves is a sought-after speaker and writer on antitrust issues. Her work has appeared in The Antitrust Source, Antitrust Magazine, and the Indiana Law Journal. She is an active member of the American Bar Association’s (ABA) Antitrust Section, where she currently serves as the Editorial Chair of The Antitrust Source and Chair of the Annual Law & Economics Institute for Judges.

Ms. Reeves has served in multiple management roles at Latham including her previous position as the Global Chair of the firm’s Mentoring Committee.

Prior to joining Latham, Ms. Reeves clerked for Judge John G. Heyburn II, Chief Judge of the United States District Court for the Western District of Kentucky, from 2002 to 2003, and for Judge Mary Beck Briscoe, current Chief Judge of the United States Court of Appeals for the Tenth Circuit, from 2003 to 2004. Ms. Reeves remains active in the alumni activities of the University of Virginia, where she recently finished a three-year appointment to the School of Law’s Alumni Council.

Ms. Reeves is consistently recognized by Chambers USA as a top antitrust lawyer in Washington, D.C. In 2016, Ms. Reeves was recognized as one of the top women working in the antitrust field globally by Global Competition Review. In 2015, Global Competition Review also recognized her as one of the world’s Top 40 Competition Lawyers Under 40, and in 2014, they named her a finalist for Lawyer of the Year – 40 and Under. She was recently recognized as one of the Washington, D.C. region’s Top 40 Lawyers Under 40 by Bisnow and was named a finalist for Best in Antitrust: Euromoney Legal Media Group Americas Women in Business Law in 2016. In addition, Ms. Reeves is listed as a top lawyer in the Who’s Who Legal: Competition 2016 guide and Who's Who Legal - Future Leaders 2017 in Competition.

Ms. Reeves’ publications and lectures include:  

  • Co-Author, "Five Global Merger Control Developments You Need To Know: 2018 Midyear Report," Law360 Competition e-newsletter (July 2018)
  • Session Chair/Moderator, ABA Antitrust Law Spring Meeting, “Inside the Intel Decision,” (April 2018)
  • Speaker, Cambridge Forum, “International Antitrust Regulation Roundtable,” (January 2018)    
  • Panelist, ABA Antitrust Section Mid-Winter Leadership Meeting, “Pharmaceutical Update,” (January 2018)
  • Panelist, ABA Antitrust in Asia Conference, “Merger Review in Asia,” (June 2016)
  • Panelist, ABA Antitrust Section Brown Bag, “The FTC’s Section 5 Statement,” (September 2015)
  • Panelist, ABA Antitrust Section Spring Meeting, “How To Settle A Patent Case After Actavis,” (April 2015)
  • Panelist, ABA Antitrust Section Brown Bag, “Merger Efficiencies: Hot Documents and Hot Data,” (October 2014)
  • Panelist, ABA Antitrust Section Spring Meeting, “The FTC Begins A Second Century: Is Past Prologue?” (March 2014)
  • “Muddying the Settlement Waters: Open Questions and Unintended Consequences Following FTC v. Actavis,” Antitrust Magazine (Fall 2013)
  • Panelist, ABA Antitrust Section Spring Meeting, “Information Exchange Update: Steely Nurses and Iron Pipes,” (April 2013)
  • “Hot Documents, CEOs as Star Witnesses, and Litigating to Win: What the FTC and DOJ’s Reinvigorated Litigation Strategy Means for Merger Review,” Competition Policy International’s Antitrust Chronicle (December 2012)
  • “The Search for Clarity in Federal Pleading Standards: Are We Close to Limiting the Intended (or Unintended) Consequences of Twombly and Iqbal,” Sedona Conference Journal (Fall 2012) (co-authored with Margaret Zwisler)
  • Lecturer, PLI Understanding the Intellectual Property License Seminar, “Antitrust Issues in Intellectual Property Licenses,” (November 2011, November 2012, November 2013)
  • Panelist, Canadian Bar Association Annual Fall Competition Law Conference, “Behavioral Economics: Junk Science?” (October 2011)
  • Panelist, George Mason Law & Economics Center: Lessons Since the Reagan Revolution at the FTC, “Section 5 of the FTC Act,” (September 2011)
  • Moderator, ABA Antitrust Section Spring Meeting, “Section 5 of the FTC Act: A Penumbra Conundrum,” (April 2011)
  • “High-Technology Mergers & the Merger Guidelines: The Search for a Silver Lining to an Otherwise Dark Cloud,” The Threshold (April 2011) (co-authored with Jason Cruise)
  • “The Pro-Competitive Value of Closed Platforms & Walled Gardens: Some Thoughts in Response to Tim Wu,” Competition Policy International’s Antitrust Chronicle (March 2011) (co-authored with Dan Wall)
  • Panelist, ABA Antitrust Section Brown Bag, “Bundled Discounts, Not Discrimination: Structuring Bundled and Loyalty Discounts to Comply with the Robinson-Patman Act and State Law,” (December 2010)
  • Panelist on multiple panels, ABA Antitrust Section Masters Course V, (September 2010): (1) “Exclusionary Practices: Tying, Exclusive Dealing, and Bundling;” (2) “IP/Antitrust: Practical Analysis and Problem Solving;” (3) “The Art of Counseling: Relationships Between Competitors – Defining a Section 1 Agreement”
  • “Effective Advocacy Before the Federal Trade Commission,” Antitrust Magazine (Summer 2010) (co-authored with Darren S. Tucker)
  • “Behavioral Antitrust: Unanswered Questions on the Horizon,” The Antitrust Source (June 2010)
  • Moderator, Antitrust in Healthcare Conference, “Application of Section 5 of the FTC Act to Health Care,” (May 2010) (co-sponsored by ABA Antitrust Section, ABA Health Law Section, and American Health Lawyers Association)
  • “Conduct Specific Tests? How the Federal Trade Commission Can Reframe the Section 5 Debate,” Competition Policy International’s Antitrust Chronicle (February 2010)
  • Roundtable Participant, Competition Policy International Roundtable on Section 5 of the FTC Act (February 2010)
  • Moderator, Brown Bag Panel Discussion, “State Sales Below Cost Laws: Everything You Need to Know About Navigating a World Without Brooke Group,” (February 2010) (co-sponsored by ABA Antitrust Section’s Pricing Conduct & Business Torts & Civil RICO Committees)
  • Panelist, ABA Fall Forum, “Shaping Antitrust Policy: The Role of the Courts,” (November 2009) (sponsored by ABA Antitrust Section)
  • “Challenges to Conglomerate Mergers: A Doctrinal Overview & Thoughts On A Possible Rebirth,” The Threshold (ABA Antitrust Section Mergers & Acquisitions Committee Newsletter) (Summer 2009)
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.